CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-09 | HILZINGER KURT J Director | Purchase | +2,792 | $0.73 | $2K | 98,629 |
| 2019-01-08 | HILZINGER KURT J Director | Purchase | +6,410 | $0.65 | $4K | 95,837 |
| 2019-01-07 | HILZINGER KURT J Director | Purchase | +5,166 | $0.63 | $3K | 89,427 |
| 2019-01-04 | HILZINGER KURT J Director | Purchase | +6,205 | $0.59 | $4K | 84,261 |
| 2019-01-03 | HILZINGER KURT J Director | Purchase | +4,200 | $0.59 | $2K | 78,056 |
| 2019-01-02 | HILZINGER KURT J Director | Purchase | +1,640 | $0.59 | $968 | 73,856 |
| 2019-01-02 | BioLexis Pte Ltd. Director | Grant or award | +4,288,624 | $0.93 | $4.0M | 61,481,879 |
| 2018-12-31 | HILZINGER KURT J Director | Purchase | +11,349 | $0.59 | $7K | 72,216 |
| 2018-12-31 | BioLexis Pte Ltd. Director | Other acquisition · Series A-1 Convertible Preferred Stock | +1,505 | 61,708 | ||
| 2018-12-28 | HILZINGER KURT J Director | Purchase | +11,910 | $0.52 | $6K | 60,867 |
| 2018-12-27 | HILZINGER KURT J Director | Purchase | +730 | $0.51 | $372 | 48,957 |
| 2018-12-26 | HILZINGER KURT J Director | Purchase | +5,714 | $0.54 | $3K | 48,227 |
| 2018-12-24 | HILZINGER KURT J Director | Purchase | +1,113 | $0.66 | $735 | 42,513 |
| 2018-12-21 | HILZINGER KURT J Director | Purchase | +3,600 | $0.65 | $2K | 41,400 |
| 2018-12-21 | THURMAN RANDY H Director | Purchase | +15,000 | $0.68 | $10K | 15,000 |
| 2018-12-03 | BioLexis Pte Ltd. Director | Grant or award | +4,288,624 | $0.93 | $4.0M | 57,193,255 |
| 2018-11-09 | Mohan Pankaj Director | Grant or award · Stock Option (Right to Buy) | +114,157 | $0.61 | $70K | 114,157 |
| 2018-11-09 | Windisch Joerg Director | Grant or award · Stock Option (Right to Buy) | +130,465 | $0.61 | $80K | 130,465 |
| 2018-11-09 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +203,851 | $0.61 | $125K | 203,851 |
| 2018-11-09 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +567,522 | $0.61 | $348K | 567,522 |
Page 15 of 20 · 386 trades